Major deals

The European Union is negotiating with Johnson & Johnson to reserve or purchase doses of the developed COVID-19 vaccine. The agreement is under development and has not yet been formally confirmed. J&J will start human clinical trials of the vaccine next month, but the EU is already looking to close deals with six possible manufacturers to provide the vaccine to 450 million people.